Step 1 topics → Endocrine → Paget Disease of Bone

Paget Disease of Bone

USMLE Step 1 trap: Confuses Paget's isolated ALP elevation with the hypercalcemia seen in hyperparathyroidism. In Paget disease, alkaline phosphatase is markedly elevated while serum calcium, phosphate, and PTH remain normal (unless the patient is immobilized).

Paget disease of bone is a chronic disorder of disordered bone remodeling, and USMLE Step 1 loves it because students consistently confuse it with both hyperparathyroidism and primary bone tumors. The key distinguishing lab: markedly elevated alkaline phosphatase with normal calcium, phosphate, and PTH — a pattern that rules out both hyperparathyroidism (which alters calcium and phosphate) and osteoporosis (which has normal labs). Osteoclasts go haywire first (lytic phase), followed by osteoblast overcompensation (mixed and sclerotic phases), producing the pathognomonic mosaic bone pattern on histology.

The exam tests Paget from multiple angles. Recall questions ask you to identify the mosaic bone pattern or name the lab findings. Application questions give you a vignette — an older man with bone pain, an enlarging skull, a new-onset bowing deformity — and ask you to connect the clinical picture to the underlying mechanism (e.g., why does this patient have heart failure?). Passage-based questions may give you biopsy findings or a lab panel and ask you to distinguish Paget from Paget mimics. The classic trap is a patient with a markedly elevated alkaline phosphatase and normal calcium, phosphate, and PTH — students who memorize 'bone disease = hypercalcemia' will pick the wrong answer every time.

What makes Paget tricky is that it looks like several diseases at once. The elevated ALP looks like it should come with hypercalcemia (it doesn't — unless the patient is immobilized). The heart failure looks like it should come from anemia (it doesn't — it's a hypervascular shunting phenomenon). The bone sclerosis looks like it could be a metastatic lesion or primary tumor. Step 1 is specifically testing whether you understand the mechanism behind each finding, not just pattern-matching buzzwords.

From real student decks
8%have cards covering this topic
0%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: An elevated alkaline phosphatase in Paget disease must be accompanied by hypercalcemia or elevated PTH.
Right: In Paget disease, alkaline phosphatase is markedly elevated while serum calcium, phosphate, and PTH remain normal (unless the patient is immobilized).
In Paget disease, the markedly elevated ALP reflects osteoblast hyperactivity compensating for runaway osteoclast resorption — it has nothing to do with parathyroid hormone or serum calcium dysregulation. Calcium, phosphate, and PTH are all normal because the remodeling is localized and the feedback axis is intact. The one exception: if a Paget patient is immobilized (e.g., bed rest after fracture), resorption outpaces formation and hypercalcemia can occur — but this is a secondary complication, not the baseline state.
Common mistake
Wrong: Paget disease is a primary bone tumor causing abnormal bone deposition only.
Right: Paget disease is a disorder of disordered bone remodeling with three phases (lytic, mixed, sclerotic), producing a characteristic mosaic pattern of woven and lamellar bone.
Paget disease is a remodeling disorder, not a neoplasm. It starts with osteoclast activation (lytic phase), triggers compensatory osteoblast activity (mixed phase), and ultimately produces dense but structurally weak bone (sclerotic phase). The mosaic pattern — irregular 'cement lines' between woven and lamellar bone on histology — is the direct result of this chaotic, asynchronous remodeling. Primary bone tumors don't produce this pattern; they replace normal bone with tumor matrix.
Common mistake
Wrong: High-output heart failure in Paget disease results from anemia rather than increased vascularity of pagetic bone.
Right: High-output heart failure in Paget disease results from markedly increased blood flow through the hypervascular pagetic bone acting as an arteriovenous shunt.
Pagetic bone is intensely hypervascular — new blood vessels proliferate to support the massive metabolic activity of dysregulated remodeling. This turns affected bone into a low-resistance, high-flow circuit functionally similar to an arteriovenous fistula. The heart compensates by increasing cardiac output, and over time this sustained high-output state leads to heart failure. Anemia can worsen symptoms but is not the primary driver — the mechanism is purely vascular.
Common mistake
Wrong: Bisphosphonates are used in Paget disease to treat hypercalcemia, as they are in malignancy.
Right: Bisphosphonates are first-line in Paget disease to suppress osteoclast-driven excessive bone resorption and reduce ALP, not to correct hypercalcemia.
Bisphosphonates work in Paget disease by inducing osteoclast apoptosis, directly targeting the root cause — excessive, disordered bone resorption. The goal is to normalize ALP and prevent complications like fractures, deformity, and sarcomatous transformation. When bisphosphonates are used in malignancy-associated hypercalcemia, the target is also osteoclasts, but the clinical problem being solved is hypercalcemia — not the case in Paget, where calcium is typically normal. Don't let the shared drug class blur the different indications.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the three phases of Paget disease (lytic, mixed, sclerotic) and understand how disordered osteoclast-then-osteoblast activity produces the mosaic bone pattern seen on histology — distinguishing it from primary bone tumors.
  2. Identify the classic clinical presentation: older adult with bone pain, skull enlargement (hat no longer fits), bowing of the tibia, hearing loss from cranial nerve VIII compression, and the serious complication of osteosarcoma transformation.
  3. Interpret the characteristic lab pattern: markedly elevated alkaline phosphatase with normal serum calcium, phosphate, and PTH — and know when calcium DOES rise (immobilization) and why high-output heart failure occurs (hypervascular bone acting as an AV shunt).
  4. Select bisphosphonates as first-line therapy and understand the mechanism — suppressing excessive osteoclast-driven bone resorption to reduce ALP and halt disease progression — not to treat hypercalcemia.

Can you avoid these mistakes?

A 68-year-old man presents with progressive enlargement of his head and bilateral leg bowing. Labs show ALP 4× normal, calcium 9.1 mg/dL, phosphate 3.5 mg/dL, PTH normal. Skull X-ray shows mixed lytic and sclerotic lesions. What is the diagnosis, and why is calcium normal despite the dramatic ALP elevation?
A patient with known Paget disease is admitted for a hip fracture and placed on bed rest. Two weeks later, labs show calcium 11.8 mg/dL. What is the mechanism of this new finding, and how does it differ from the usual Paget lab pattern?
A biopsy of pagetic bone is reviewed. The pathologist describes irregular cement lines creating a 'mosaic' or 'jigsaw puzzle' pattern. What process produces this histologic appearance, and what does it distinguish Paget disease from?
A 72-year-old woman with Paget disease develops progressive dyspnea and a high-output state on echo. She is not anemic. What is the mechanism of her heart failure, and what is the first-line treatment to reduce the underlying driver of this complication?

Related topics

Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Thyroid (HPT) Axis Hypothalamic-Pituitary-Gonadal (HPG) Axis Hormone Signaling (Peptide vs Steroid)

See how your Anki deck covers this topic.

Upload your deck for a free audit →